Navigation Links
Advantages and motivations uncertain behind use of brachytherapy for breast cancer radiotherapy
Date:12/16/2011

Accelerated partial breast irradiation using brachytherapy (APBIb) for the treatment of breast cancer has been rapidly increasing over the last several years in the U.S. as an alternative to standard whole-breast irradiation (WBI), according to a study published December 16th in the Journal of the National Cancer Institute.

Various types of APBI recurrence (external beam radiation, intraoperative radiotherapy, brachytherapy using multiple interstitial catheters, or intracavitary brachytherapy using a balloon catheter) deliver radiation to breast tissue at the highest risk of recurrence. Advantages of these techniques include decreased treatment time and less radiation to uninvolved portions of the breast and normal tissues. Disadvantages of APBI include the possibility that tumor cells in a different part of the breast will remain untreated, which could lead to increased local recurrence. Because of the potential limitations of APBI, in 2009 the American Society for Radiation Oncology (ASTRO) convened a task force of breast cancer experts to develop criteria for use of APBI off-protocol. They proposed three groups of APBI appropriateness: suitable, cautionary and unsuitable, based on patient characteristics and clinical factors.

Because of the growing popularity of APBIb in particular, Jona Hattangadi, M.D., of the Department of Radiation Oncology at the Brigham and Women's Hospital and Harvard Medical School in Boston, and colleagues performed a retrospective analysis of data from the Surveillance, Epidemiology, and End Results (SEER) database of women who had received either APBIb or WBI between 2000 and 2007. In line with ASTRO guidelines, the researchers classified the 138,815 women as "suitable", "cautionary", or "unsuitable" for APBIb.

The researchers found that 3,576 of the 138,815 patients had received APBIb: 32% of whom would have been considered suitable, 29.6% cautionary, and 36.2% unsuitable. The overall use
'/>"/>

Contact: Zachary Rathner
Zachary.Rathner@oup.com
301-841-1286
Journal of the National Cancer Institute
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. For back, neck pain, artificial disc replacement has cost, outcome advantages over fusion surgery
2. New Polio Vaccine Shows Major Advantages: Study
3. Comparison shows robot-assisted option offers advantages for kidney surgery
4. Policymakers should prepare for major uncertainties with Medicaid expansion
5. Diagnosis uncertainty increases anxiety in patients
6. The Worst Is Over, but the Road to Growth Is Uncertain - The 17th Annual CFO Rising Conference & Exhibition
7. Supercomputer reveals new details behind drug-processing protein model
8. Researchers search for culprit behind dry eyes, mouths and more
9. Unvaccinated Kids Behind Largest U.S. Measles Outbreak in Years: Study
10. Antioxidants Not Behind Red Wines Healthy Effect on Heart: Study
11. Scientists Discover Key Gene Mutation Behind Lou Gehrigs Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... DC (PRWEB) May 05, 2015 “Given that ... the findings in the CDC report are a major step ... rethink health for everyone. For the past 30 years, data ... the standard model. Today we see the urgency and the ... achieve the best health outcomes for all,” said Jane L. ...
(Date:5/5/2015)... The global lab automation market is expected ... in 2014, at an estimated CAGR of 6.7% from ... market on the basis of equipment and software, application, ... basis of application, Lab Automation Market is classified into ... Drug discovery is a major application of the lab ...
(Date:5/5/2015)... The newly minted Regan Arts has just released a unique self-help ... from his 20 years working in the field of wilderness therapy. ... a parenting book and why this one, she replied, “What resonates ... it is a journey, not a destination...that the question is not ... together and sometimes not...that each of our struggles is unique. What ...
(Date:5/5/2015)... Georgia (PRWEB) May 05, 2015 ... of Victoria BC announced the Skedans Sensor Collaboration ... platform, for mobile and web app developers, provides tooling ... airborne and mobile sensors. , The Skedans Sensor Collaboration ... the intersection of the Internet of Things, Web Real ...
(Date:5/5/2015)... 2015 Information Innovators Inc. ... the federal government, today announced its acquisition of ... provides solutions exclusively to federal government customers through ... cyber security, health services, and program management support. ... credentials as a Third Party Assessment Organization (3PAO) ...
Breaking Medicine News(10 mins):Health News:“Its about time,” Declares the National Alliance for Hispanic Health on First CDC Study of Hispanic Health 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 5Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 2Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 3Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4
... Serena Gordon HealthDay Reporter , FRIDAY, March 25 (HealthDay ... health today, but five years ago his body was wasting away. ... know what. That something was type 1 diabetes, and ... his life, he,s healthy now because he spends a lot of ...
... 2011 The U.S. Food and Drug Administration (FDA) announced ... the deadliest and most difficult-to-treat form of skin cancer. The ... of any kind ever shown in a large, randomized phase ... patients with metastatic melanoma who no longer respond to standard ...
... CHAPEL HILL, N.C. The American Association for Cancer ... professor of medicine and a member of UNC Lineberger ... Foundation-AACR Grant for Translational Breast Cancer Research. The ... Annual Meeting, to be held in Orlando, Florida, April ...
... , FRIDAY, March 25 (HealthDay News) -- Researchers have ... live in the intestine, leading to immune system problems. ... said the team at Ohio State University. The communities of ... potentially harmful bacteria. The study is published in the ...
... in French . , It sounds unbelievably ... for asthma treatment, attached to the drug prescription, improves ... often signal a management failure," said Dr. Francine Ducharme, ... the Sainte-Justine University Hospital Centre. "This research shows that, ...
... any given time tens of thousands of these neurons might be ... trying to be heard by his friend across a crowded room, ... heard above the din. Researchers from the Center for ... University and the University of Pittsburgh, have found two ways that ...
Cached Medicine News:Health News:Nick Jonas Lives Large, Despite Diabetes 2Health News:Nick Jonas Lives Large, Despite Diabetes 3Health News:FDA approves ipilimumab, an immunotherapy, to treat metastatic melanoma 2Health News:FDA approves ipilimumab, an immunotherapy, to treat metastatic melanoma 3Health News:FDA approves ipilimumab, an immunotherapy, to treat metastatic melanoma 4Health News:UNC physician-scientist receives grant to study breast cancer brain metastases 2Health News:Young asthmatics are leaving emergency rooms missing critical documentation 2Health News:'Can you hear me now?' Researchers detail how neurons decide how to transmit information 2
(Date:5/5/2015)... 5, 2015  Adeptus Health Inc. (NYSE: ADPT ... pricing of the previously announced offering of 2,100,000 shares ... shares are to be sold by the Company, and ... of Sterling Partners (the "Selling Stockholder"), at a price ... the Company and the Selling Stockholder have granted the ...
(Date:5/5/2015)... May 5, 2015   InspireMD, Inc. (NYSE MKT: ... systems, announced today that it will release its full financial ... Monday, May 11 th before the open, followed by ... financial results and business outlook. Participants should call ... 542-4135 (International) and request the InspireMD call. A live webcast ...
(Date:5/5/2015)... , May 5, 2015 Ardelyx, ... company focused on cardio-renal, gastrointestinal, and metabolic diseases, ... trial evaluating tenapanor in Stage 3 chronic kidney ... albuminuria did not meet the primary endpoint of ... compared to patients receiving placebo. ...
Breaking Medicine Technology:Adeptus Health Inc. Announces Pricing of Common Stock Offering 2Adeptus Health Inc. Announces Pricing of Common Stock Offering 3Adeptus Health Inc. Announces Pricing of Common Stock Offering 4InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 3Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 2Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 3Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 4Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 5Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 6
... CHICAGO, Nov. 18, 2010 Northwestern Memorial ... pilot study that will test whether operable lung cancer ... and better outcomes by hardwiring data systems to reduce ... standards.  The 18-month trial co-sponsored by the Commission on ...
... Nov. 18, 2010  Prism Pharmaceuticals, Inc. announced ... (FDA) has approved the supplemental new drug application ... and only premixed intravenous (IV) bag formulation of ... is indicated for initiation of treatment and prophylaxis ...
Cached Medicine Technology:Lung Cancer Patients the Centerpiece for Northwestern Medicine Quality of Care Study 2Lung Cancer Patients the Centerpiece for Northwestern Medicine Quality of Care Study 3Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use NEXTERONE® (amiodarone HCl) Premixed Injection 2Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use NEXTERONE® (amiodarone HCl) Premixed Injection 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: